MedTrace Logo

Diagnostic and Therapeutic Applications of Microarrays in Lung Transplantation

NCT02812290 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 700

Last updated 2025-11-20

No results posted yet for this study

Summary

Objective: To evaluate the potential impact of molecular phenotyping of transbronchial biopsies in lung transplant recipients with allograft dysfunction, and the potential for developing a safer endobronchial mucosal biopsy format.

Conditions

  • Lung Transplant Rejection

Interventions

PROCEDURE

Lung transplant biopsy bites.

In the second phase of the study, two biopsy bites from the same patient will be collected to assess tissue sampling variability.

Sponsors & Collaborators

  • University of Alberta

    lead OTHER

Principal Investigators

  • Philip F Halloran, MD, PhD · Faculty of Medicine and Dentistry, University of Alberta

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-05-31
Primary Completion
2026-06-30
Completion
2026-12-31

Countries

  • United States
  • Australia
  • Austria
  • Canada
  • Czechia
  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02812290 on ClinicalTrials.gov